India ' s Biocon Biologics Launches Biosimilar for Humira in US India ' s Biocon Biologics Launches Biosimilar for Humira in US
India ' s Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie ' s blockbuster rheumatoid arthritis drug Humira in the United States.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news
More News: Arthritis | Dermatology | Health | Humira | India Health | Rheumatoid Arthritis | Rheumatology | Skin | USA Health